BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12865321)

  • 1. Retinoic acid-induced stimulation of sodium iodide symporter expression and cytotoxicity of radioiodine in prostate cancer cells.
    Spitzweg C; Scholz IV; Bergert ER; Tindall DJ; Young CY; Göke B; Morris JC
    Endocrinology; 2003 Aug; 144(8):3423-32. PubMed ID: 12865321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone enhances the cytotoxic effect of radioiodine therapy in prostate cancer cells expressing the sodium iodide symporter.
    Scholz IV; Cengic N; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1108-16. PubMed ID: 15001595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
    Unterholzner S; Willhauck MJ; Cengic N; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2006 Jan; 91(1):69-78. PubMed ID: 16234306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.
    Spitzweg C; Zhang S; Bergert ER; Castro MR; McIver B; Heufelder AE; Tindall DJ; Young CY; Morris JC
    Cancer Res; 1999 May; 59(9):2136-41. PubMed ID: 10232600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
    Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
    Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
    Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
    Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
    J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy of colon cancer following tissue-specific sodium iodide symporter gene transfer.
    Scholz IV; Cengic N; Baker CH; Harrington KJ; Maletz K; Bergert ER; Vile R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2005 Feb; 12(3):272-80. PubMed ID: 15510175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of 188rhenium as an alternative radionuclide for treatment of prostate cancer after tumor-specific sodium iodide symporter gene expression.
    Willhauck MJ; Sharif Samani BR; Gildehaus FJ; Wolf I; Senekowitsch-Schmidtke R; Stark HJ; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4451-8. PubMed ID: 17698909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to gene therapy with sodium/iodide symporter.
    Spitzweg C; Morris JC
    Exp Clin Endocrinol Diabetes; 2001; 109(1):56-9. PubMed ID: 11573142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.
    Willhauck MJ; Sharif-Samani B; Senekowitsch-Schmidtke R; Wunderlich N; Göke B; Morris JC; Spitzweg C
    Breast Cancer Res Treat; 2008 May; 109(2):263-72. PubMed ID: 17636401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein promoter-targeted sodium iodide symporter gene therapy of hepatocellular carcinoma.
    Willhauck MJ; Sharif Samani BR; Klutz K; Cengic N; Wolf I; Mohr L; Geissler M; Senekowitsch-Schmidtke R; Göke B; Morris JC; Spitzweg C
    Gene Ther; 2008 Feb; 15(3):214-23. PubMed ID: 17989705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells.
    Kogai T; Kanamoto Y; Li AI; Che LH; Ohashi E; Taki K; Chandraratna RA; Saito T; Brent GA
    Endocrinology; 2005 Jul; 146(7):3059-69. PubMed ID: 15817668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid induces sodium/iodide symporter gene expression and radioiodide uptake in the MCF-7 breast cancer cell line.
    Kogai T; Schultz JJ; Johnson LS; Huang M; Brent GA
    Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8519-24. PubMed ID: 10890895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo sodium iodide symporter gene therapy of prostate cancer.
    Spitzweg C; Dietz AB; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
    Gene Ther; 2001 Oct; 8(20):1524-31. PubMed ID: 11704812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.
    Jeong H; Kim YR; Kim KN; Choe JG; Chung JK; Kim MK
    Nucl Med Biol; 2006 Oct; 33(7):875-82. PubMed ID: 17045167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.
    Schmutzler C; Winzer R; Meissner-Weigl J; Köhrle J
    Biochem Biophys Res Commun; 1997 Nov; 240(3):832-8. PubMed ID: 9398654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells.
    Heltemes LM; Hagan CR; Mitrofanova EE; Panchal RG; Guo J; Link CJ
    Cancer Gene Ther; 2003 Jan; 10(1):14-22. PubMed ID: 12489024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of sodium iodide symporter gene expression in FRTL-5 rat thyroid cells.
    Spitzweg C; Joba W; Morris JC; Heufelder AE
    Thyroid; 1999 Aug; 9(8):821-30. PubMed ID: 10482376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.